Showing results (381-390 of 437) with videos related to

Sort By:
Pageof 44
The Prostate|January 22, 2019
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancerDaniel P Petrylak, Philip Kantoff, Nicholas J Vogelzang, et al.
The Lancet. Oncology|August 13, 2021
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialJohann S de Bono, Niven Mehra, Giorgio V Scagliotti, et al.
The Lancet. Oncology|January 14, 2022
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 studyArlene O Siefker-Radtke, Andrea Necchi, Se Hoon Park, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
APOLLO: A genome-scale metabolic reconstruction resource of 247,092 diverse human microbes spanning multiple continents, age groups, and body sitesAlmut Heinken, Timothy Otto Hulshof, Bram Nap, et al.
Cell Systems|February 13, 2025
A genome-scale metabolic reconstruction resource of 247,092 diverse human microbes spanning multiple continents, age groups, and body sitesAlmut Heinken, Timothy Otto Hulshof, Bram Nap, et al.
Nature Biotechnology|February 20, 2018
Recon3D enables a three-dimensional view of gene variation in human metabolismElizabeth Brunk, Swagatika Sahoo, Daniel C Zielinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2020
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial CancerMatthew D Galsky, Amir Mortazavi, Matthew I Milowsky, et al.
The Prostate|November 20, 2019
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 studyDaniel P Petrylak, Nicholas J Vogelzang, Kamal Chatta, et al.
Science Advances|January 18, 2023
Extensive field evidence for the release of HONO from the photolysis of nitrate aerosolsSimone T Andersen, Lucy J Carpenter, Chris Reed, et al.
Cancer|August 7, 2020
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancerTian Zhang, Michael R Harrison, Peter H O'Donnell, et al.
Pageof 44